Recent 2024 multi-society guidance from the American Society of Anesthesiologists (ASA) and other professional organizations (including AGA, ASMBS, ISPCOP, and SAGES) indicates that most patients can continue GLP-1 receptor agonists before elective surgery with appropriate risk stratification and precautions
For patients who strongly prefer a needle-free approach, daily semaglutide or tirzepatide ODTs may be worth considering
If youre a caregiver, youll need to monitor them closely for sensitivities or reactions as you continue treating them
Hard data is what matters
To convert each dose into syringe units, see the peptide dosage calculator
Patients with type 2 diabetes and obesity represent another population who may derive metabolic advantages, though it is important to note that Zepbound is not FDA-approved for diabetes treatment (tirzepatide is marketed as Mounjaro for diabetes management)